Browsing: Discusses

Unknown Attendee As drug development teams finalize molecule optimization, packing development begins. Often a time-consuming process of evaluating multiple components, suppliers and test results. For prefilled…

Follow Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia February 3, 2026 10:30 AM EST Company Participants Rémy…

Operator Good afternoon, and welcome to Hera Group’s new Business Plan to 2029 presentation. The floor now goes to Mr. Cristian Fabbri, Hera’s Executive Chairman. Cristian…

FollowPlay Earnings CallPlay Earnings Call Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering January 22, 2026 9:00 AM EST…

FollowPlay Earnings CallPlay Earnings Call Corvus Pharmaceuticals, Inc. (CRVS) Discusses Phase 1 Clinical Trial Results of Soquelitinib in Atopic Dermatitis with Focus on Cohort 4 January…

Meta Platforms, Inc. (NASDAQ:META) is one of the stocks Jim Cramer recently looked at. Cramer highlighted the company’s nuclear ambitions, and he also expressed how he…

Union Minister Ashwini Vaishnaw met senior Nvidia officials to discuss the development of sovereign graphics processing units (GPUs) and the manufacturing of advanced data processing devices…

FollowPlay Earnings CallPlay Earnings Call COMPASS Pathways plc (CMPS) Discusses Clinical Trial Plans for PTSD and Commercial Preparations for Treatment-Resistant Depression January 7, 2026 10:00 AM…

FollowPlay Earnings CallPlay Earnings Call Alliance Entertainment Holding Corporation (AENT) Discusses Operating Platform, Recent Financial Performance, and Strategic Priorities January 5, 2026 4:15 PM EST Company…

Robert Kraft This podcast for informational purposes only and is not provided as financial, legal or any other advice. The information is not investment advice or…